Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients-Reference-Cited by-同舟云学术

Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients

Published:2006-05 Issue:1 Volume:36 Page:43-49
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Vergne Laurence,Stuyver Lieven,Van Houtte Margriet,Butel Christelle,Delaporte Eric,Peeters Martine

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference25 articles.

1. Polymorphism in protease and reverse transcriptase and phenotypic drug resistance of HIV-1 recombinant CRF02_AG isolates from patients with no prior use of antiretroviral drugs in Abidjan, Cote d’Ivoire;Adje-Toure;J Acquir Immune Defic Syndr,2003

2. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness;Bocket;Antivir Ther,2005

3. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors;Descamps;AIDS,1998

4. Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses;Descamps;J Virol,1997

5. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP;Eshleman;J Infect Dis,2005

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Trends in HIV-1 Subtypes and Drug Resistance in Children from Argentina over a 15-Year Period (2006-2021);Revista de investigaci�n Cl�nica;2024-02-26

2. APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants;Frontiers in Virology;2022-07-14

3. Drugs Resistance Against Viral Diseases;Biochemistry of Drug Resistance;2021

4. In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa;AIDS;2016-11-13

5. Targeting HIV Prevention Based on Molecular Epidemiology Among Deeply Sampled Subnetworks of Men Who Have Sex With Men;Clinical Infectious Diseases;2015-06-30